SABINA DUMBA: Open Payments
NPI 1093941189 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 4 payments from 4 companies in 2025. Trend: 2023 $988 · 2024 $703 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Ardelyx, Inc. | 1 | $119 |
| Gilead Sciences, Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: BREZTRI, IBSRELA, JARDIANCE.
Industry payments across NE — which companies pay providers there.
